Sec. 4041. Cures Innovation Fund
241 words·~1 min read·
/bill/114/hr/6/rh/section-4041·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
There is hereby established in the Treasury of the United States a fund to be known as the Cures Innovation Fund (in this section referred to as the Fund ). There is hereby appropriated to the Fund, out of any funds in the Treasury not otherwise appropriated, $110,000,000 for each of fiscal years 2016 through 2020. Amounts in the Fund shall be available, as provided by appropriation Acts, for making expenditures for carrying out the following: Section 229A of the Public Health Service Act, as added by section 1123 (relating to data on natural history of diseases).
Part E of title II of the Public Health Service Act, as added by section 1141 (relating to Council for 21st Century Cures). Section 2001 and the amendments made by such section (relating to development and use of patient experience data to enhance structured risk-benefit assessment framework). Section 2021 and the amendments made by such section (relating to qualification of drug development tools). Section 2062 and the amendments made by such section (relating to utilizing evidence from clinical experience).
Section 2161 (relating to grants for studying the process of continuous drug manufacturing). Funds appropriated by subsection (b)— shall be used to supplement, not supplant, amounts otherwise made available to the National Institutes of Health and the Food and Drug Administration; and notwithstanding any transfer authority in any appropriation Act, shall not be used for any purpose other than the expenditures listed in subsection (c).